Menu
|
Content
Twitter
Linkedin
YouTube
Home
Print
Fr
ançais
En
glish
Home
HERV Approach
Long COVID
Clinical Trials
News & Media
Investors
GNRO Shares
Documentation
Press releases
Presentations
Annual reports / Registration documents
AMF Regulated information
Company governance
General meetings
Financial agenda
Investor relations
Contacts
About GeNeuro
Contact
GNRO Shares
Documentation
Press releases
Presentations
Annual reports / Registration documents
AMF Regulated information
Company governance
General meetings
Financial agenda
Investor relations
Contacts
AMF Regulated information
Half-year financial report at June 30, 2023
Half-year financial report at June 30, 2022
SECURITIES NOTE 22-149
Half-year financial report at June 30, 2021
Declaration of transaction on own shares
Half-year financial report at June 30, 2020
Voting Rights and Share Repurchase Program Details ENG 31.01.2020
Securities Note 20-024
Universal Registration Document D.20-0023
Half-year financial report at June 30, 2019
Half-year financial report at June 30, 2018
Half-year financial report at June 30, 2017
2016 Reference Document free translation
Half-year financial report at June 30, 2016
Description of share repurchase programs (in French)
Share liquidity contract
Half-yearly report on the liquidity contract with Gilbert Dupont (June 30, 2023)
Half-yearly report on the liquidity contract with Gilbert Dupont (December 30, 2022)
Half-yearly report on the liquidity contract with Gilbert Dupont (June 30, 2022)
Half-yearly report on the liquidity contract with Gilbert Dupont (December 31, 2021)
Half-yearly report on the liquidity contract with Gilbert Dupont (June 30, 2021)
Half-yearly report on the liquidity contract with Gilbert Dupont (December 31, 2020)
Half-yearly report on the liquidity contract with Gilbert Dupont (June 30, 2020)
Annual report on the liquidity contract with Gilbert Dupont (December 31, 2019)
Half-yearly report on the liquidity contract with Gilbert Dupont (June 30, 2019)
Total voting rights and shares forming the company’s share capital
Monthly statement of total voting rights and shares forming the company's share capital - 2023
Monthly statement of total voting rights and shares forming the company's share capital - 2021
Monthly statement of total voting rights and shares forming the company's share capital - 2020